Merck: The Worst Has Been Avoided (Rating Upgrade) [Seeking Alpha]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Seeking Alpha
As a result, I am upgrading Merck's rating from 'Hold' to 'Buy'. Merck ( NYSE: MRK ) is one of the largest pharmaceutical companies in the world, occupying one of the leading positions in the global vaccines and oncology drugs markets. Investment thesis Since the publication of my last article on January 8, 2024 , the company's share price, after a brief bull run, began to move sideways despite Merck announcing a lot of positive news in recent months. On April 25 , Merck published financial results for the first three months of 2024, which pleasantly surprised me with the progress in the development of its pipeline of product candidates, guidance, growth in its operating income and gross margins despite the acquisitions of Harpoon Therapeutics and Caraway Therapeutics, as well as the conclusion of a multi-billion dollar deal with Daiichi Sankyo ( OTCPK:DSKYF So, the company's management raised expectations for its total sales from $62.7-$64.2 billion to $63.1-$64.3 billion
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- [Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]Latest
- Here's Why Merck (MRK) Stock Has Outperformed Industry YTD [Yahoo! Finance]Yahoo! Finance
- Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates [Yahoo! Finance]Yahoo! Finance
- Global Veterinary Eye Care Market Size, Share & Trends Analysis Report 2024-2030: Collaborative Efforts Advance Early Detection, Laser Therapy Gains Popularity, New Technologies Elevate Care [Yahoo! Finance]Yahoo! Finance
- Cramer says these 10 stocks helped the Dow briefly crack 40,000 [CNBC]CNBC
MRK
Earnings
- 4/25/24 - Beat
MRK
Sec Filings
- 5/15/24 - Form 424B5
- 5/15/24 - Form POSASR
- 5/6/24 - Form 144
- MRK's page on the SEC website